Last reviewed · How we verify
NCT05953454
Effectiveness of Pain Neuroscience Education on Clinical and Psychosocial Variables in Chronic Low Back Pain
NA trial testing Pain neuroscience Education in Chronic Low-back Pain in 69 participants. Status unknown.
1 December 2024
Quick facts
| Lead sponsor | Universidad Santo Tomas, Chile |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 69 |
| Start date | 1 April 2024 |
| Primary completion | 1 December 2024 |
| Estimated completion | 30 December 2024 |
Drugs / interventions tested
- Pain neuroscience Education
Conditions studied
- Chronic Low-back Pain — all drugs for Chronic Low-back Pain →
Sponsor
Universidad Santo Tomas, Chile
Who can join
Adults 45 to 60, any sex, with Chronic Low-back Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An educational intervention on the neurophysiology of chronic pain will be provided. The content of the intervention will be identical in the experimental groups (group and individual). The intervention has an active educational approach based on reconceptualizing the maladaptive beliefs that influence the fear-avoidance behavior of the participants through updated contents of the neuroscience of pain. The effects of the intervention will be compared between the groups and the influence of the social determinants of health on the effects will also be determined. The investigators hypothesize that there will be significant differences in favor of the group intervention group over the individual intervention groups. Furthermore, the effects will be influenced by the social determinants of health in both experimental groups.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Models of care for managing non-specific low back pain.
Docking S, Sridhar S, Haas R, Mao K, et al · · 2025 · cited 5× · PMID 40052535 · DOI 10.1002/14651858.cd015083.pub2 -
Effectiveness of in-group <i>versus</i> individually administered pain neuroscience education on clinical and psychosocial outcomes in patients with chronic low back pain: randomized controlled study protocol.
Salazar-Méndez J, Cuyul-Vásquez I, Ponce-Fuentes F, Núñez-Cortés R, et al · · 2024 · cited 1× · PMID 38832030 · DOI 10.7717/peerj.17507
Verify or expand the search:
- PubMed search for NCT05953454
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Low-back Pain
Currently open trials in the same condition.
- NCT06891625 — Movement Performance in Persons With Chronic Back Pain · NA · recruiting
- NCT06568198 — Modulation Effect of tACS on Chronic Low Back Pain · Phase 2 · recruiting
- NCT06825390 — AuriculoTherapy NeuroImaging · NA · recruiting
- NCT04824248 — Weight Reduction in CLBP · NA · recruiting
- NCT07055802 — Effects Of Inversion Table Therapy Vs MT On Pain And Lumbar Flexibility In Patients With Chronic Low Back Pain · NA · active not recruiting
Other Universidad Santo Tomas, Chile trials
Trials by the same sponsor.
- NCT07278141 — Effects of Resistance and Dual-Task Training on Physical, Oculomotor, and Executive Functions in Older Adults With MCI · NA · not yet recruiting
- NCT06482970 — Effectiveness of Exercise Plus Pain Neuroscience Education on Brain Function in Knee Osteoarthritis · NA · not yet recruiting
- NCT04314115 — Prevention of Mental Health Problems in People Exposed to a Recent Highly Stressful Event. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05953454 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Santo Tomas, Chile
- Last refreshed: 20 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05953454.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing